Evidence map›Paper›PMID 10921956›Full record

ArticleJournal of clinical microbiology2000

Characterization of Bartonella clarridgeiae flagellin (FlaA) and detection of antiflagellin antibodies in patients with lymphadenopathy.

A Sander, A Zagrosek, W Bredt, E Schiltz, Y Piémont, C Lanz, C Dehio

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Evaluation of the available animal models forOne health (Amsterdam, Netherlands) · 2024
    Review
  3. Article
  4. Article
  5. Phylogeny and putative virulence gene analysis of Bartonella bovis.The Journal of veterinary medical science · 2018
    Article
  6. Carrion's Disease: the Sound of Silence.Clinical microbiology reviews · 2018
    Review
  7. Molecular Mechanisms ofFrontiers in cellular and infection microbiology · 2018
    Review
  8. Coexistence of Bartonella henselae and B. clarridgeiae in populations of cats and their fleas in Guatemala.Journal of vector ecology : journal of the Society for Vector Ecology · 2015
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

A SanderInstitute for Medical Microbiology and Hygiene, University of Freiburg, Freiburg, Germany. sander@ukl.uni-freiburg.de
A Zagrosek
W Bredt
E Schiltz
Y Piémont
C Lanz
C Dehio
Institute of Medical Microbiology and Hygiene · DEMax Planck Institute for Biology · DECzech Academy of Sciences, Institute of Organic Chemistry and Biochemistry · CZInstitut de Virologie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cat scratch disease (CSD) is a frequent clinical outcome of Bartonella henselae infection in humans. Recently, two case reports indicated Bartonella clarridgeiae as an additional causative agent of CSD. Both pathogens have been isolated from domestic cats, which are considered to be their natural reservoir. B. clarridgeiae and B. henselae can be distinguished phenotypically by the presence or absence of flagella, respectively. Separation of the protein content of purified flagella of B. clarridgeiae by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblot analysis indicated that the flagellar filament is mainly composed of a polypeptide with a mass of 41 kDa. N-terminal sequencing of 20 amino acids of this protein revealed a perfect match to the N-terminal sequence of flagellin (FlaA) as deduced from the sequence of the flaA gene cloned from B. clarridgeiae. The flagellin of B. clarridgeiae is closely related to flagellins of Bartonella bacilliformis and several Bartonella-related bacteria. Since flagellar proteins are often immunodominant antigens, we investigated whether antibodies specific for the FlaA protein of B. clarridgeiae are found in patients with CSD or lymphadenopathy. Immunoblotting with 724 sera of patients suffering from lymphadenopathy and 100 healthy controls indicated specific FlaA antibodies in 3.9% of the patients' sera but in none of the controls. B. clarridgeiae FlaA is thus antigenic and expressed in vivo, providing a valuable tool for serological testing. Our results further indicate that B. clarridgeiae might be a possible etiologic agent of CSD or lymphadenopathy. However, it remains to be clarified whether antibodies to the FlaA protein of B. clarridgeiae are a useful indicator of acute infection.

Indexed as

Amino Acid SequenceAnimalsAntibodies, BacterialBartonellaBartonella InfectionsBase SequenceBlotting, WesternCatsCat-Scratch DiseaseCloning, MolecularFlagellaFlagellinHumansLymphatic DiseasesMolecular Sequence DataSequence Analysis, DNAAntibodies, BacterialflaA protein, bacteriaFlagellin

Identifiers

PMID10921956
PMCPMC87154
OpenAlexW2139025411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.